Answer
Rezurock (belumosudil mesilate) is contraindicated in patients with hypersensitivity to the active substance or any excipient listed in section 6.1.
Sources for this answer
- REZUROCK 200 mg film-coated tablets.SANOFI · emc · SmPC §4.3 Contraindications · Version 8Document updated
Sources checked